Darlene Madore
Nurse Practitioner · Brockton, MANPI 1487018735
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (46.5%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 42 manufacturers reported payments, led by CSL Behring at 37.8% of the total. Among nurse practitioner clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 825 payments — averaging $50.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- CSL Behring$16K
- Pfizer$8K
- AstraZeneca$5K
- Genentech USA, Inc.$4K
- Regeneron Healthcare Solutions, Inc.$1K
- GSK$1K
- plus $7K from 36 others
What the payments were for
- Consulting fees$2,5436%
- Speaking & faculty fees$19,50247%
- Travel & lodging$2,8547%
- Food & beverage$16,82940%
- Education$1930%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$41,920 in reported general payments places this provider in the 95th percentile of 3,855 nurse practitioner providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 62 | $235,792 |
| Dupixent SyringeDupilumab | 62 | $225,494 |
| GammaplexImmun Glob G(Igg)/Gly/Iga 0-50 | 29 | $136,871 |
| TezspireTezepelumab-Ekko | 27 | $115,080 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 92 | $95,416 |
| HizentraImmun Glob G(Igg)/Pro/Iga 0-50 | 26 | $61,931 |
| Gammagard LiquidImmun Glob G(Igg)/Gly/Iga Ov50 | 22 | $43,442 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 30 | $37,523 |
| Spiriva RespimatTiotropium Bromide | 48 | $31,054 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 34 | $13,168 |
| Arnuity ElliptaFluticasone Furoate | 48 | $12,499 |
| Breo ElliptaFluticasone/Vilanterol | 24 | $11,800 |
| SymbicortBudesonide/Formoterol Fumarate | 17 | $8,079 |
| Epinephrine | 43 | $7,451 |
| Bevespi AerosphereGlycopyrrolate/Formoterol Fum | 11 | $6,989 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaTezspire, Breztri Aerosphere, Symbicort, Bevespi Aerosphere | $5,023 | $225,564147 claims |
| Bio Products Laboratory USA, Inc.Gammaplex | $15 | $136,87129 claims |
| GSKTrelegy Ellipta, Arnuity Ellipta, Breo Ellipta, Incruse Ellipta | $1,160 | $66,838118 claims |
| CSL BehringHizentra | $15,839 | $61,93126 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Gammagard Liquid | $851 | $43,44222 claims |
| Boehringer IngelheimSpiriva Respimat | $260 | $31,05448 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,855 nurse practitioner providers in Massachusetts.
Other nurse practitioner in Brockton
- Deborah CohanBrockton$9K
- Judith KingBrockton$8K
- Gregory QuinlanBrockton$7K
- Lauri WelchNorth Chelmsford$110K
- Teresa FogarenBoston$102K
- Carolyn MetivierBoston$93K
- Deborah GearySalem$80K
- Amberly ChaplinWorcester$56K
- Nancy SydowN Chelmsford$35K
- Miu Lai NgBoston$33K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.